Ezaki Glico Co., Ltd. (JP:2206)
:2206
Top Page
Ezaki Glico Co., Ltd.
(2206)
Select Model
Select Model
Rating:65Neutral
Price Target:
¥6,297.00
▲(25.89% Upside)
Action:ReiteratedDate:02/18/26
The score is driven by strong financial stability from a conservative balance sheet and supportive technical momentum, but is held back by deteriorating profitability, uneven cash-flow consistency, and a demanding valuation (high P/E with only a modest dividend yield).
Positive Factors
Conservative balance sheet
Extremely low leverage and a conservative capital structure materially reduce refinancing and solvency risk. Over the next 2–6 months this durability gives flexibility to absorb cost shocks, fund targeted capex or M&A selectively, and preserve investment in brands without pressure to deleverage.
Negative Factors
Profitability has materially weakened
Rapid margin erosion signals persistent cost inflation or pricing pressure that compresses operating leverage. If structural, lower margins reduce reinvestment capacity, constrain cash available for strategic initiatives, and weaken earnings resiliency across economic cycles.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Extremely low leverage and a conservative capital structure materially reduce refinancing and solvency risk. Over the next 2–6 months this durability gives flexibility to absorb cost shocks, fund targeted capex or M&A selectively, and preserve investment in brands without pressure to deleverage.
Read all positive factors
Ezaki Glico Co., Ltd. (2206) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥390.59B
Dividend Yield1.64%
Average Volume (3M)146.34K
Price to Earnings (P/E)68.5
Beta (1Y)0.27
Revenue Growth8.40%
EPS Growth-23.50%
CountryJP
Employees5,563
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)-35.06
Shares Outstanding68,468,570
10 Day Avg. Volume137,410
30 Day Avg. Volume146,340
Financial Highlights & Ratios
PEG Ratio-1.80
Price to Book (P/B)1.24
Price to Sales (P/S)0.95
P/FCF Ratio17.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)178.44
Revenue Forecast (FY)¥368.40B
Ezaki Glico Co., Ltd. Business Overview & Revenue Model
Company Description
Ezaki Glico Co., Ltd. (2206) is a leading Japanese food company, best known for its confectionery products, particularly its iconic Pocky snack and various other snacks, ice creams, and dairy products. Founded in 1922, Glico operates across multip...
How the Company Makes Money
Ezaki Glico generates revenue primarily through the sale of its confectionery products, including biscuits, chocolates, and snacks, which form the bulk of its sales. The company also earns revenue from its ice cream and dairy products, which have ...
Ezaki Glico Co., Ltd. Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
86
Very Positive
Cash Flow
58
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 341.60B | 361.39B | 331.13B | 332.59B | 303.92B | 338.57B |
| Gross Profit | 128.29B | 135.12B | 127.67B | 123.85B | 110.75B | 158.03B |
| EBITDA | 21.88B | 15.77B | 29.06B | 34.05B | 27.93B | 35.09B |
| Net Income | 8.19B | 5.04B | 8.11B | 14.13B | 8.10B | 13.52B |
Balance Sheet | ||||||
| Total Assets | 369.01B | 394.13B | 380.38B | 397.93B | 371.71B | 359.57B |
| Cash, Cash Equivalents and Short-Term Investments | 51.84B | 68.63B | 60.24B | 97.20B | 91.93B | 102.25B |
| Total Debt | 7.16B | 154.00M | 3.36B | 40.97B | 32.67B | 31.06B |
| Total Liabilities | 102.36B | 115.59B | 107.78B | 134.81B | 126.95B | 118.39B |
| Stockholders Equity | 266.05B | 277.90B | 272.00B | 262.54B | 244.29B | 240.79B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 19.26B | -6.79B | 9.69B | -8.89B | 4.89B |
| Operating Cash Flow | 0.00 | 29.39B | 3.84B | 28.06B | 16.80B | 28.65B |
| Investing Cash Flow | 0.00 | -16.08B | -12.37B | -8.61B | -20.14B | -29.19B |
| Financing Cash Flow | 0.00 | -6.92B | -39.15B | -6.18B | -10.28B | -4.86B |
Ezaki Glico Co., Ltd. Technical Analysis
Positive
5002.00
Price Trends
5851.82
Positive
5590.51
Positive
5188.11
Positive
Market Momentum
55.30
Positive
49.81
Neutral
18.30
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2206, the sentiment is Positive. The current price of 5002 is below the 20-day moving average (MA) of 6073.00, below the 50-day MA of 5851.82, and below the 200-day MA of 5188.11, indicating a neutral trend. The MACD of 55.30 indicates Positive momentum. The RSI at 49.81 is Neutral, neither overbought nor oversold. The STOCH value of 18.30 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:2206.
Ezaki Glico Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥683.71B | 15.92 | 9.18% | 1.13% | 3.53% | 4.88% | |
66 Neutral | ¥398.86B | 13.58 | 7.90% | 1.95% | 5.82% | -13.40% | |
65 Neutral | ¥390.59B | 68.53 | 1.86% | 1.64% | 8.40% | -23.50% | |
64 Neutral | ¥92.56B | 7.83 | ― | 1.47% | 20.44% | 1199.18% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥1.08T | 13.62 | 5.97% | 2.96% | 2.79% | -6.46% | |
59 Neutral | ¥433.68B | 10.37 | ― | 2.42% | 2.33% | -8.76% |
* Consumer Defensive Sector Average
JP:2206
Ezaki Glico Co., Ltd.
6,021.00
1,368.80
29.42%
JP:2229
CALBEE
3,089.00
246.00
8.65%
JP:2269
Meiji Holdings Co
3,915.00
619.83
18.81%
JP:2212
Yamazaki Baking Co
3,375.00
515.15
18.01%
JP:2220
Kameda Seika Co., Ltd.
4,390.00
405.80
10.19%
JP:2264
Morinaga Milk Industry Co., Ltd.
4,889.00
1,750.68
55.78%
Ezaki Glico Co., Ltd. Corporate Events
Ezaki Glico Board Rejects Activist Shareholder’s Push for Director Changes and Potential Privatization
Feb 13, 2026
Ezaki Glico has disclosed that it received a shareholder proposal from LONGCHAMP SICAV, represented by Dalton Investments, seeking to nominate two outside directors, authorize large-scale share buybacks, revise restricted stock compensation, and a...
Ezaki Glico Launches ¥25 Billion Share Buyback and Cancellation Plan
Feb 13, 2026
Ezaki Glico has authorized a substantial share buyback of up to 4.6 million common shares, representing 7.23% of its outstanding stock excluding treasury shares, with a maximum outlay of ¥25 billion. The purchases will be executed on the Toky...
Ezaki Glico Books ¥3.4 Billion Impairment on Powdered Baby Milk Assets
Feb 13, 2026
Ezaki Glico announced it has recorded a fixed asset impairment loss related to facilities used in its powdered baby milk business, a part of its Dairy Business. After reassessing the future recoverability of these assets under Japan’s impair...
Ezaki Glico Posts Higher Sales but Profit Slump for FY2025 Amid Margin Pressure
Feb 13, 2026
Ezaki Glico reported a 9.1% increase in net sales to ¥361.4 billion for the fiscal year ended December 31, 2025, but operating profit fell 21.0% and profit attributable to owners of parent dropped 37.9%. Earnings per share declined to ¥7...
Ezaki Glico Revises 2025 Financial Forecasts Due to Product Recall and Sluggish Sales
Dec 17, 2025
Ezaki Glico Co., Ltd. has revised its full-year financial forecast for 2025, citing a reduction in expected net sales and profits due to a chocolate recall and sluggish sales in its ice cream and chilled products sectors. Despite these downward re...
Ezaki Glico Initiates Voluntary Recall of Chocolate Products Due to Flavor Issues
Dec 8, 2025
Ezaki Glico Co., Ltd. has announced a voluntary recall of 20 chocolate products, including popular items like Pocky Chocolate, due to unintended flavor variations caused by spice contamination during warehouse renovations. While there are no safet...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.